Literature DB >> 9837784

Association of CrkL with STAT5 in hematopoietic cells stimulated by granulocyte-macrophage colony-stimulating factor or erythropoietin.

J Ota1, F Kimura, K Sato, N Wakimoto, Y Nakamura, N Nagata, S Suzu, M Yamada, S Shimamura, K Motoyoshi.   

Abstract

CrkL is an adapter protein comprising Src homology (SH) 2 and SH3 domains. We investigated the molecule(s) associated with CrkL in factor-dependent cell lines. In the granulocyte-macrophage colony-stimulating factor (GM-CSF)-dependent cell lines TF-1 and UT-7, an approximately 95-kDa tyrosine-phosphorylated protein was precipitated along with CrkL after GM-CSF stimulation. The same protein was also observed when we used the erythropoietin (EPO)-dependent cell line UT-7/EPO, in an EPO stimulation-dependent manner. We identified it as STAT5 (signal transducer and activator of transcription 5, 96 kDa) by STAT5-specific antibodies. The direct binding of the SH2 domain of CrkL to STAT5 was demonstrated in far Western blotting and pull-down experiments using the glutathione S-transferase (GST) fusion construct CrkL-SH2. The addition of the oligopeptide containing phosphotyrosine 694 in STAT5A impaired the association between GST-CrkL-SH2 and STAT5. Furthermore, in a gel shift assay using prolactin-inducible element (PIE) as the probe, the DNA binding activity of STAT5 was inhibited by the interaction with GST-CrkL-SH2 in vitro. Finally, we found that STAT5 associated with CrkL did not bind to PIE sequence. These results suggest that CrkL participates in the Janus kinase (JAK)-STAT pathway by direct association with STAT5. Copyright 1998 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9837784     DOI: 10.1006/bbrc.1998.9445

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  6 in total

Review 1.  Preclinical and clinical studies of the NEDD9 scaffold protein in cancer and other diseases.

Authors:  Elena Shagisultanova; Anna V Gaponova; Rashid Gabbasov; Emmanuelle Nicolas; Erica A Golemis
Journal:  Gene       Date:  2015-05-09       Impact factor: 3.688

Review 2.  Molecular Pathways Involved in the Development of Congenital Erythrocytosis.

Authors:  Jana Tomc; Nataša Debeljak
Journal:  Genes (Basel)       Date:  2021-07-28       Impact factor: 4.096

3.  Susceptibility-Associated Genetic Variation in NEDD9 Contributes to Prostate Cancer Initiation and Progression.

Authors:  Dong Han; Jude N Owiredu; Bridget M Healy; Muqing Li; Maryam Labaf; Jocelyn S Steinfeld; Susan Patalano; Shuai Gao; Mingyu Liu; Jill A Macoska; Kourosh Zarringhalam; Kellee R Siegfried; Xin Yuan; Timothy R Rebbeck; Changmeng Cai
Journal:  Cancer Res       Date:  2021-02-25       Impact factor: 12.701

4.  Signal transducer and activator of transcription (STAT)5 activation by BCR/ABL is dependent on intact Src homology (SH)3 and SH2 domains of BCR/ABL and is required for leukemogenesis.

Authors:  M Nieborowska-Skorska; M A Wasik; A Slupianek; P Salomoni; T Kitamura; B Calabretta; T Skorski
Journal:  J Exp Med       Date:  1999-04-19       Impact factor: 14.307

5.  Combined Inhibition of Bcl2 and Bcr-Abl1 Exercises Anti-Leukemia Activity but Does Not Eradicate the Primitive Leukemic Cells.

Authors:  Michele Massimino; Paolo Vigneri; Stefania Stella; Elena Tirrò; Maria Stella Pennisi; Laura Nunziatina Parrinello; Calogero Vetro; Livia Manzella; Fabio Stagno; Francesco Di Raimondo
Journal:  J Clin Med       Date:  2021-11-29       Impact factor: 4.241

Review 6.  STAT5 as a Key Protein of Erythropoietin Signalization.

Authors:  Zuzana Tóthová; Jana Tomc; Nataša Debeljak; Peter Solár
Journal:  Int J Mol Sci       Date:  2021-07-01       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.